Funding
Innovate UK Smart grant · Healthtech

Opto Biosystems wins Innovate UK backing for glioma neural interface

The Smart award supports development of a minimally invasive device for monitoring brain cancer patients.

By RoundOS Funding desk

Opto Biosystems, now Coherence Neuro, announced Innovate UK Smart funding on June 19, 2024, to advance a minimally invasive neural interface for patients with glioma. Innovate UK’s project data records a £346,422 grant offer towards the £494,888 development project.

The work focuses on remote monitoring of neurological activity to help inform brain cancer care. Led by Elise Jenkins, the project was scheduled to run from March 2024 to May 2025. The company said the support would help it move the technology towards human studies.

Use of funds

Development of a minimally invasive neural interface for glioma care

Funding history

Innovate UK Smart grant · This round£346.4K
December 2022 pre-seed announced March 2023£1.9MCancer Tech Accelerator grant disclosed August 2022£70K

Sources

  1. Opto announces Innovate UK Smart funding for glioma neural interfacelinkedin.com · Jun 19, 2024
  2. UKRI grant offer to Coherence Neuro project 10099579gtr.ukri.org
  3. ukri.org

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026

Related